Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872572 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 8 Pages |
Abstract
Conclusion: Curative RT plus rIL-2 immunotherapy provided an efficient, effective means of treating angiosarcoma of the scalp. Arterial or intratumoral administration combined with systemic administration of rIL-2 may prolong survival. Additional studies with detailed treatment protocols are recommended.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Takayuki M.D., Hajime M.D., Satoshi M.D., Katsuya M.D., Masanori M.D., Hiroshi M.D., Yoshiki M.D., Katsumasa M.D., Yoshiyuki M.D., Hiroshi M.D., Hiromi M.D., Yoiichi M.D., Masutaka M.D., Yukunori M.D.,